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In the MEN 2B syndrome, MCT and pheochromocytomas develop in patients who have a characteristic body habitus and multiple ganglioneuromata of both the enteric nervous system and mixed peripheral nerves [2, 3] .
Genetic tests for MEN 2 have recently been developed to simplify the screening of individuals from affected kindreds whose mutation is known. Most of these feature the use of altered restriction sites to allow the detection of specific pathogenic mutations in the RET protooncogene [4] [5] [6] [7] . This approach, while extremely useful when a restriction site is altered, is limited by the fact that some pathogenic mutations do not result in such an alteration [4] 
DEVELOPMENT OF DGGE ASSAYS FOR RET GENE MUTATIONS
Because of the substantial effort required to seek mutations in the RET gene by direct sequencing, we sought to develop a reliable method with which we could find mutations more rapidly. DGGE, which detects differences in the melting behav- In particular, the heteroduplexes will have nonhomologous "bubbles" present at the site of the mutation. The bubbles in the heteroduplexes result in their having a lower melting temperature than the homoduplexes. Consequently, an affected individual will display two to four bands on DGGE, one for each DNA species. In contrast, normal subjects will display only a single band, as their PCR products contain only wild-type homoduplex DNA. This difference in pattern is dramatic and evident.
Thus far, we have found appropriate DGGE conditions for the detection of mutations in exons 10, 11, and 16, as shown in Fig. 1 . We used the primer program [17] to estimate the melting behavior of each PCR product by processively calculating the annealing temperature of 20-hp windows. This analysis revealed that residue 634 is contained within an unusually high meltingpoint region of the RET gene. This fact required that we use a 61/62-base GG clamp and a higher gel temperature to detect mutations at this site. We used a two-step amplification protocol to incorporate this "double" GC clamp.
APPLICATION OF DGGE TO A THREE-GENERATION KINDRED
We used the exon 10 DGGE assay to test 16 members of a family carrying the C620R mutation, as shown in Fig. 2 [10, 13, 14, 20, 26] 
CLINICAL FEATURES OF MEN 2 AND SCREENING ISSUES
The tumors classified as MEN 2 may occur either as components of the syndrome or as sporadic neoplasms-and the clinician must be able to distinguish between these. Various features, including pathological findings and age of onset, help to distinguish familial from sporadic disease but are far from absolute criteria for doing so [32] [33] [34] [35] [36] . products <500 bp long [11] . Because the method cannot detect mutations in the highest melting temperature domain of the molecule, GG-clamping introduces a high melting-point segment of DNA at the end of a PCR primer so as to place amplified mutations in a context that maximizes their chance of detection [16] . In the case of RET exon 11, the standard GC clamp did not allow the detection of codon 634 mutations, but these were revealed by extending the clamp length. In a recent report, Attie et 
